Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells

被引:0
作者
Hui Lyu
Jingcao Huang
Zhimin He
Bolin Liu
机构
[1] University of Colorado Anschutz Medical Campus,Department of Pathology, School of Medicine
[2] Sichuan University,Department of Hematology, Hematologic Research Laboratory, West China Hospital
[3] Guangzhou Medical University,Cancer Research Institute and Affiliated Cancer Hospital
来源
Biological Procedures Online | 2018年 / 20卷
关键词
HER3; miRNA-replacement therapy; Functional cooperation; HER2; Breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 309 条
[1]  
Baselga J(2009)Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 Nat Rev Cancer 9 463-475
[2]  
Swain SM(2009)ErbB receptors and signaling pathways in cancer Curr Opin Cell Biol 21 177-184
[3]  
Hynes NE(2003)The deaf and the dumb: the biology of ErbB-2 and ErbB-3 Exp Cell Res 284 54-65
[4]  
MacDonald G(2010)ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation Proc Natl Acad Sci U S A 107 7692-7697
[5]  
Citri A(2010)HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy Clin Cancer Res 16 1373-1383
[6]  
Skaria KB(2014)Regulation of ERBB3/HER3 signaling in cancer Oncotarget 5 10222-10236
[7]  
Yarden Y(2013)Oncogenic ERBB3 mutations in human cancers Cancer Cell 23 603-617
[8]  
Shi F(2013)HER3 overexpression and survival in solid tumors: a meta-analysis J Natl Cancer Inst 105 266-273
[9]  
Telesco SE(2003)The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation Proc Natl Acad Sci U S A 100 8933-8938
[10]  
Liu Y(2008)A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy Cancer Res 68 5878-5887